ArticleEULAR rheumatology open2026
Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort study.
Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correspondence on "Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort study" by "Nielsen et al."EULAR rheumatology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Despite the importance of early diagnosis in inflammatory arthritis (IA), particularly rheumatoid arthritis (RA), diagnostic time intervals often exceed months even in early arthritis recognition clinics (EARCs). This study aimed to describe patient flow through an open-access arthralgia clinic (OAC). In addition, to explore associations between referral pathways, diagnostic time intervals, and disease activity in RA patients. Methods: In this Danish single-centre retrospective cohort study, patients referred from general practitioners to the OAC (2013-2018) underwent brief rheumatological assessments and were either discharged or referred to the EARC. Patients assessed in the OAC and later diagnosed with RA were compared with RA control patients referred directly to the EARC. Results: Of 761 patients seen at the OAC, 156 (20%) were referred directly to the EARC, while 605 (80%) were discharged; 50 (7%) of these were later re-referred to the EARC. At the EARC, 87 patients (11%) were diagnosed with IA, including 37 (5%) with RA, of whom 32 were referred directly from the OAC, and 5 were directly re-referred after initial OAC discharge. Compared with RA controls, the 32 RA patients initially assessed at the OAC had a shorter median time from symptom onset to diagnosis (92 vs 192 days, Conclusions: In this observational study, the OAC was associated with shorter diagnostic time intervals for RA patients, supporting the potential of open-access triage in early assessment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.